Recent studies indicate that high expression of PKM2 synergizes with PD-L1 to predict worse survival in human lung adenocarcinoma, while WSX1 downregulation is closely correlated with poor prognosis in HCC. This evidence concerns the gene CD274 and lung adenocarcinoma.